Latest Blog Posts Tagged "GBA"
March 09, 2018
More than 40 experts convened at the MJFF offices to discuss how to advance therapies against Parkinson's genetic target GBA.
February 14, 2017
This study is a major step for PD research as it is the first drug trial where one's genetic information determines eligibility and is testing a potential therapy to slow or stop disease progression.
February 06, 2017
Barbara and Jay Robinson discuss their decision to participate in Parkinson's genetics research.
December 01, 2016
Two recently published studies, one MJFF-funded, point to mutations in the GBA gene that may predispose some to cognitive problems with Parkinson's disease.
November 22, 2016
For Jessica O'Brien, Facebook was a place to post pictures of her dogs, until it became a starting point in her journey to understand Parkinson's disease.
June 17, 2016
Discovery of this gene provides a new potential therapeutic target for PD treatment.
October 27, 2015
Next week, MJFF staff will attend the URJ Biennial in Orlando, FL to lead a panel discussion on the genetic implications of Parkinson's disease in the Ashkenazi Jewish population.
July 14, 2015
This week, Chicago's "You & Me This Morning" show featured Dr. Tatiana Foroud and Jon Gilman to discuss genetic testing for Parkinson's-related genes in the Foundation's PPMI study.
March 24, 2015
The Parkinson's Progression Markers Initiative (PPMI), a large-scale biomarker study sponsored by The Michael J. Fox Foundation (MJFF) is expanding to study individuals with a genetic mutation of the
March 05, 2015
In recent years research into the GBA gene and the GCase protein has expanded, offering another avenue to avoiding or treating Parkinson's disease.